Literature DB >> 10365247

Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin.

J Melendez-Zajgla1, E Cruz, V Maldonado, A M Espinoza.   

Abstract

HeLa cells undergo apoptosis after exposure to cisplatin. Since mitochondria have recently been proposed as a probable effector of this type of cell death, we performed an analysis using the fluorescent cation rhodamine 123, which is transported actively by this organelle. Cisplatin induces a decrease in the mitochondrial staining, as assessed by cytofluorometric analysis. Microscopic analysis demonstrated that this effect was accompanied by damage of the mitochondria. These features were not exclusive of cisplatin, as other antineoplasic agents (taxol, etoposide) elicited similar effects. These results point toward the notion of a general effect of antineoplasic drugs over the mitochondria during induction of apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365247     DOI: 10.1080/15216549900201853

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  4 in total

1.  Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells.

Authors:  Grazyna Nowak
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

2.  Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro.

Authors:  Ahmad Zaim Mat Pauzi; Swee Keong Yeap; Nadiah Abu; Kian Lam Lim; Abdul Rahman Omar; Suraini Abdul Aziz; Adam Leow Thean Chow; Tamilselvan Subramani; Soon Guan Tan; Noorjahan Banu Alitheen
Journal:  Chin Med       Date:  2016-11-15       Impact factor: 5.455

3.  Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells.

Authors:  Yu-Guo Yuan; Sangiliyandi Gurunathan
Journal:  Int J Nanomedicine       Date:  2017-09-05

4.  Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway.

Authors:  Baishen Chen; Zhuojian Shen; Duoguang Wu; Xuan Xie; Xia Xu; Liangzhan Lv; Honglue Dai; Ju Chen; Xiangfeng Gan
Journal:  Biomed Res Int       Date:  2019-03-27       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.